cardiovascular system
|
• increased cardiomyocyte cross-sectional area more so than in wild-type mice in response to pressure overload
|
|
• more so than in wild-type mice in response to pressure overload
|
|
• more so than in wild-type mice in response to pressure overload
|
|
• more so than in wild-type mice in response to pressure overload
• however, the phenotype is improved when mice are treated with N-acetyl-L-cysteine
|
|
• increased cardia hypertrophy (with increased heart weight and increased cardiomyocyte cross-sectional area), cardiac fibrosis and increased lung weight more so than in wild-type mice in response to pressure overload
• however, the phenotypes are improved when mice are treated with N-acetyl-L-cysteine
|
cellular
|
• exacerbated reduction complex I, II and IV activity in response to pressure overload
|
respiratory system
|
• more so than in wild-type mice in response to pressure overload
|
homeostasis/metabolism
|
• increased cardia hypertrophy (with increased heart weight and increased cardiomyocyte cross-sectional area), cardiac fibrosis and increased lung weight more so than in wild-type mice in response to pressure overload
• however, the phenotypes are improved when mice are treated with N-acetyl-L-cysteine
|
muscle
|
• increased cardiomyocyte cross-sectional area more so than in wild-type mice in response to pressure overload
|
|
• more so than in wild-type mice in response to pressure overload
• however, the phenotype is improved when mice are treated with N-acetyl-L-cysteine
|
growth/size/body
|
• more so than in wild-type mice in response to pressure overload
|
|
• more so than in wild-type mice in response to pressure overload
|


Analysis Tools